Dania Porco, MS, MBA, CGC

Title: Director in Clinical Science BioMarin Pharmaceutical Inc.

Bio: Dania is a certified genetic counselor who has served in various roles in industry with expertise in rare diseases including Medical Affairs, Clinical Development, Patient Advocacy and Clinical Operations. She joined BioMarin in 2015 from Prosensa Therapeutics where she was working on antisense oligonucleotide therapies for Duchenne Muscular Dystrophy. Currently Dania is a Director in Clinical Science at BioMarin Pharmaceutical Inc.

2023 FUTURES: RNA targeted Therapeutics Sessions Part 2

Continued updates from relevant companies in the space. These presentations will be followed by a moderated Q&A opportunity.

Mark Stahl, MD, PhD

Senior Medical Director, Clinical Development

Avidity Biosciences

See more from same speaker

Nerissa Kreher, MD, MBA

Chief Medical Officer

Entrada Therapeutics

See more from same speaker

Jane Larkindale, DPhil

VP of Clinical Science PepGen

See more from same speaker

Dania Porco, MS, MBA, CGC

Director in Clinical Science BioMarin Pharmaceutical Inc.

See more from same speaker

Michael Tillinger, MD

VP of Clinical Development Wave Life Sciences

See more from same speaker

Video
Share this:
Beginning the Journey - diagnosed 0-3 yearsGrowth and Transformation - diagnosed 3-6 yearsSpreading Wisdom - diagnosed 6+ years